The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 6,973 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,441 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
ACORDA THERAPEUTICS INC | COM | 00484M106 | 591 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 2,102 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
ALIMERA SCIENCES INC | COM | 016259103 | 1,354 | 974,318 | SH | SOLE | 974,318 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 3,965 | 165,690 | SH | SOLE | 165,690 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 3,242 | 152,837 | SH | SOLE | 152,837 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 25,664 | 924,483 | SH | SOLE | 924,483 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 21,271 | 1,030,072 | SH | SOLE | 1,030,072 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 3,820 | 185,000 | SH | Call | SOLE | 0 | 0 | 0 | |
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 938 | 168,685 | SH | SOLE | 168,685 | 0 | 0 | ||
CAS MED SYS INC | COM PAR | 124769209 | 5,522 | 4,760,151 | SH | SOLE | 4,760,151 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 8,218 | 1,358,351 | SH | SOLE | 1,358,351 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,873 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 484 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 3,848 | 107,765 | SH | SOLE | 107,765 | 0 | 0 | ||
EDGE THERAPEUTICS INC | COM | 279870109 | 15,437 | 1,504,612 | SH | SOLE | 1,504,612 | 0 | 0 | ||
ESSA PHARMA INC | COM | 29668H104 | 242 | 442,000 | SH | SOLE | 442,000 | 0 | 0 | ||
EVOLENT HEALTH INC | CL A | 30050B101 | 7,113 | 280,600 | SH | SOLE | 280,600 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 1,724 | 70,000 | SH | Put | SOLE | 70,000 | 0 | 0 | |
GLAUKOS CORP | COM | 377322102 | 999 | 24,100 | SH | Put | SOLE | 24,100 | 0 | 0 | |
GOGO INC | COM | 38046C109 | 577 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
IMMUNOGEN INC | COM | 45253H101 | 356 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
IMMUNOMEDICS INC | COM | 452907108 | 14,128 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 858 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 2,280 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 959 | 100,292 | SH | SOLE | 100,292 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 25,101 | 3,415,044 | SH | SOLE | 3,415,044 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,381 | 324,000 | SH | Call | SOLE | 0 | 0 | 0 | |
IRIDEX CORP | COM | 462684101 | 17,184 | 1,737,540 | SH | SOLE | 1,737,540 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 51,436 | 365,000 | SH | Put | SOLE | 365,000 | 0 | 0 | |
JOHNSON & JOHNSON | COM | 478160104 | 5,292 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
JUNO THERAPEUTICS INC | COM | 48205A109 | 2,391 | 80,000 | SH | Put | SOLE | 80,000 | 0 | 0 | |
KITE PHARMA INC | COM | 49803L109 | 7,775 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
LANNET INC | COM | 516012101 | 1,828 | 89,600 | SH | Put | SOLE | 89,600 | 0 | 0 | |
MANNKIND CORP | COM NEW | 56400P706 | 46 | 32,300 | SH | Put | SOLE | 32,300 | 0 | 0 | |
MYRIAD GENETICS INC | COM | 62855J104 | 501 | 19,400 | SH | Put | SOLE | 19,400 | 0 | 0 | |
NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 9,911 | 945,737 | SH | SOLE | 945,737 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 2,179 | 72,866 | SH | SOLE | 72,866 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 299 | 10,000 | SH | Put | SOLE | 10,000 | 0 | 0 | |
OMEROS CORP | COM | 682143102 | 796 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
ONCOBIOLOGICS INC | COM | 68235M105 | 29 | 29,082 | SH | SOLE | 29,082 | 0 | 0 | ||
ONCOBIOLOGICS INC | *W EXP 02/18/201 | 68235M113 | 17 | 96,833 | SH | SOLE | 96,833 | 0 | 0 | ||
ONCOBIOLOGICS INC | *W EXP 05/18/201 | 68235M121 | 9 | 96,833 | SH | SOLE | 96,833 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 4,057 | 551,196 | SH | SOLE | 551,196 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 7,000 | 373,507 | SH | SOLE | 373,507 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 1,410 | 200,500 | SH | SOLE | 200,500 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 264 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 29,506 | 382,300 | SH | Put | SOLE | 382,300 | 0 | 0 | |
SPECTRANETICS CORP | COM | 84760C107 | 1,536 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
TESARO INC | COM | 881569107 | 3,315 | 23,700 | SH | SOLE | 23,700 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 25,658 | 3,080,145 | SH | SOLE | 3,080,145 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 1,333 | 160,000 | SH | Call | SOLE | 0 | 0 | 0 | |
VERSARTIS INC | COM | 92529L102 | 857 | 49,100 | SH | Put | SOLE | 49,100 | 0 | 0 | |
VIEWRAY INC | COM | 92672L107 | 4,441 | 686,387 | SH | SOLE | 686,387 | 0 | 0 | ||
VIVEVE MED INC | COM NEW | 92852W204 | 5,098 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
WEBMD HEALTH CORP | COM | 94770V102 | 1,935 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 933 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
ZOGENIX INC | COM NEW | 98978L204 | 4,375 | 301,700 | SH | SOLE | 301,700 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,450 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 |